If you have experienced one of these safety concerns please submit a to the TGA. Your report will contribute to our monitoring of these products. My medicine or medical device is mentioned in an alert communication, what should I do? The TGA advises all consumers to follow the advice provided in the communication. Consumers should NOT stop using a medicine or medical device without first seeking the advice of their health professional; unless this is advised in the alert communication. How does the Early Warning System alert differ from the TGA Recall Communications? The Early Warning System alert communication advises consumers, health professionals and industry about new safety information on therapeutic products following the outcome of an investigation. An alert does not necessarily mean that a product is considered to be unsafe. A recall communication provides advice to consumers, health professionals and industry about a defective therapeutic good and the recall action undertaken in the Australian market. Recall actions are usually due to unacceptable quality, safety, efficacy /performance or presentation. Existing web page () Safety information No therapeutic product is ever completely risk free. Some risks may be known when a medicine or medical device is first registered. However, some information only comes to light after more people use the products. This section includes current and historic recalls of medicines and medical devices, advice that the TGA has issued about products, monitoring communications, information on reporting problems and how the safety of therapeutic goods is monitored. Existing web page () Alerts Alerts provide important information and recommendations therapeutic goods. Even though an alert has been issued, it does not necessarily mean a product has been found to be unsafe. Links to alerts issued by the TGA during the current year Links to alerts issued by the TGA since 1998 Alerts provide important information and recommendations about therapeutic goods Existing web page ()
If you have experienced one of these safety concerns please submit a to the TGA. Your report will contribute to our monitoring of these products. My medicine or medical device is mentioned in an alert communication, what should I do? The TGA advises all consumers to follow the advice provided in the communication. Consumers should NOT stop using a medicine or medical device without first seeking the advice of their health professional; unless this is advised in the alert communication. How does the Early Warning System alert differ from the TGA Recall Communications? The Early Warning System alert communication advises consumers, health professionals and industry about new safety information on therapeutic products following the outcome of an investigation. An alert does not necessarily mean that a product is considered to be unsafe. A recall communication provides advice to consumers, health professionals and industry about a defective therapeutic good and the recall action undertaken in the Australian market. Recall actions are usually due to unacceptable quality, safety, efficacy /performance or presentation. Existing web page () Safety information No therapeutic product is ever completely risk free. Some risks may be known when a medicine or medical device is first registered. However, some information only comes to light after more people use the products. This section includes current and historic recalls of medicines and medical devices, advice that the TGA has issued about products, monitoring communications, information on reporting problems and how the safety of therapeutic goods is monitored. Existing web page () Alerts Alerts provide important information and recommendations therapeutic goods. Even though an alert has been issued, it does not necessarily mean a product has been found to be unsafe. Links to alerts issued by the TGA during the current year Links to alerts issued by the TGA since 1998 Alerts provide important information and recommendations about therapeutic goods Existing web page ()
consult-anztpa-early-warning-system-130308-1_0.docx